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Abstract
Background: Some plants had been used in the treatment of cancer and one of these has attracted scientific
interest, the Euphorbia tirucalli (E. tirucalli), used in the treatment of asthma, ulcers, warts has active components
with activities scientifically proven as antimutagenic, anti-inflammatory and anticancer.
Methods: We evaluate the influence of the antitumoral fraction of the E. tirucalli latex in the larynx squamous cell
carcinoma (Hep-2), on the morphology, cell proliferation and gene expression. The Hep-2 cells were cultivated in
complete medium (MEM 10 %) and treated with E. tirucalli latex for 1, 3, 5 and 7 days. After statistically analyzing
the proliferation of the tested cells, the cells were cultivated again for RNA extraction and the Rapid Subtractive
Hybridization (RaSH) technique was used to identify genes with altered expression. The genes found using the
RaSH technique were analyzed by Gene Ontology (GO) using Ingenuity Systems.
Results: The five genes found to have differential expression were validated by real-time quantitative PCR. Though
treatment with E. tirucalli latex did not change the cell morphology in comparison to control samples, but the cell
growth was significantly decreased. The RaSH showed change in the expression of some genes, including ANXA1,
TCEA1, NGFRAP1, ITPR1 and CD55, which are associated with inflammatory response, transcriptional regulation,
apoptosis, calcium ion transport regulation and complement system, respectively. The E. tirucalli latex treatment
down-regulated ITPR1 and up-regulated ANXA1 and CD55 genes, and was validated by real-time quantitative PCR.
Conclusions: The data indicate the involvement of E. tirucalli latex in the altered expression of genes involved in
tumorigenic processes, which could potentially be applied as a therapeutic indicator of larynx cancer.
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Background
The head and neck squamous cell carcinoma (HNSCC)
represents malignant tumors arising primarily in the oral
cavity, tongue, floor of the mouth, tonsils, pharynx and
larynx. Worldwide HNSCC is the fifth most common can-
cer and it accounts for about 6 % among all cancers [1].
This tumor originates from various anatomic structures
including the craniofacial bones, soft tissues, salivary
glands, skin, and mucosal membranes [2].
The main risk factors for larynx squamous cell carcin-
oma (LSCC) are smoking and alcohol consumption [3].
Family history is another important risk factor for this
cancer, suggesting that genetic factors may contribute to
susceptibility of this disease [4]. Others aspects that can
modify cancer risk factors of the head and neck are the
polymorphisms in drug metabolizing enzymes (DMEs)
and prevalence of variant genotypes of cytochrome P450
(CYP) 1A1, 1B1, 2E1 or glutathione-S-transferase M1
(null). Furthermore, strong associations of the poly-
morphic genotypes of DMEs with cases of pharyngeal
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and oral cavity cancer who were tobacco chewers or al-
cohol users demonstrate that gene-environment interac-
tions may explain differences in genetic susceptibility for
cancers of the oral cavity, pharynx and larynx [5].
Some authors have reported that DNA alterations are
responsible for the onset of carcinogenesis that usually
occur in genes involved with proteins regulating cell cycle,
cell growth, and differentiation. These are classified as
oncogenes and tumor suppressor genes [6]. In HNSCC,
the oncogenes H-ras, c-myc, EGFR and TGF-β are often
activated and the tumor suppressor genes such as TP53,
p16, FHIT, PTEN, Rb and APC are inactivated [7, 8].
Other factors that may contribute to LSCC include diet,
oral hygiene, body mass, environmental pollution, certain
working conditions associated with industries such as me-
tallurgy and petrochemical and infections by human papil-
lomavirus - HPV, particularly types 16 and 18 and
Epstein-Barr virus which appear to be associated with the
development of more aggressive tumors [7, 9–11]. The
treatment for this neoplasm is defined depending on the
type of cell, degree of differentiation, location, extent,
presence of lymph node metastases, and macroscopic
characteristics with bone and muscle tumor involvement.
Conventional methods used for treatment are surgery,
chemotherapy, and radiation therapies, but all these
methods are considered highly invasive. Surgery can cause
irreversible aesthetic injuries with possible functional al-
terations [12]. However, some plants have been used in
the treatment of cancer as alternative therapies in an at-
tempt to soften the damage caused by conventional
methods. The Euphorbia tirucalli (E. tirucalli), popularly
known as aveloz, which is used in the herbal treatment of
asthma, ulcers, warts and tumors in general has attracted
scientific interest [13, 14].
Originating from Africa, E. tirucalli belonging to the
family Euphorbiaceae, was subsequently introduced in
other countries, it has some compounds that have been
scientifically proven to have biological activities such as
antiviral, anticancer for breast, antibacterial, anti-
inflammatory, antimutagenic, antitumor and larvicidal
[13, 15–18]. In addition, some authors have reported that
a lectin isolated from the latex of E. tirucalli, called Eutiru-
callin showed biological activities such as neutrophils re-
cruitment and cytokine production by macrophages [19].
An alternative that justifies its antitumorigenic potential is
antimutagenicity. Substances with antimutagenic poten-
tials increase the efficiency of repair mechanisms thereby
acting as protective agents that decrease the frequency of
DNA damage while controlling the disorderly prolifera-
tion of tumor cells [17].
The euphol (tetracyclic triterpene alcohol isolated
from the latex of E. tirucalli) showed anticancer effects,
inhibiting the growth of human gastric cancer cells and
tumor development, demonstrating its great value and
potential for use in disease therapy [20]. Anti-
inflammatory properties of euphol was observed in skin
diseases, because it markedly inhibited TPA (12-O-tetra-
decanoilphorbol-13-acetato)-induced inflammatory re-
sponse, demonstrating that euphol can be used as an
alternative therapy in skin diseases [21].
To investigate the effects of E. tirucalli in LSCC, we eval-
uated the influence of this herbal medicine on the morph-
ology, cell proliferation and gene expression in Hep-2 cells.
We also identified the signaling pathways where genes
modulated by E. tirucalli participate, which are important
for tumorigenic and the inflammatory process.
Methods
Hep-2 culture conditions
The Hep-2 cell line originally established from an epi-
dermoid carcinoma of the larynx (ATCC, Rockville,
Maryland, USA), was obtained and seeded at a density
of 1 × 106 cells/ml per 75 cm2 culture flask (Corning,
NY, USA). Minimum Essential Medium (MEM - Culti-
lab, Campinas, SP, Brazil) was used at pH 7.5 and sup-
plemented with 10 % fetal calf serum (Cultilab), 1 %
non-essential amino acids and 1 % antibiotic/antimycotic
(Invitrogen Corporation, Carlsbad, CA, USA) and cul-
tured at 37 °C under an atmosphere of 5 % CO2.
Pharmacological treatments
The Hep-2 cells were subdivided into three groups: a)
control that was not manipulated, b) the group that was
submitted to the addition of vehicle (ethanol) and c) an
experimental group where E. tirucalli latex was added at
concentrations of 0.25 to 250 μg/ml. The experiments
were conducted for periods of 1, 3, 5, and 7 days to de-
termine the statistically significant time for further use
in the methodology, for all the three groups.
The sap from E. tirucalli was initially extracted with
hexane through an incision in the trunk and branches of
the adult plant, and the resulting precipitate was ex-
tracted with n-butanol. The active fraction of this latex,
diluted in this polar solvent, was used to treat the cells.
In this butanol fraction of the E. tirucalli latex, ingenol-
3-hexanoate was used to obtain a useful composition for
the treatment of disease. Synthesis and modifications
were done by Kyolab Laboratories (Campinas, Brazil), by
Dr. Luiz Francisco Pianowski.
Separation of the butanol fraction by HPLC (High Per-
formance Liquid Chromatography) allowed the com-
pounds present to be taken off in group scales, mainly
by size. In a column chromatography separation with sil-
ica gel Sephadex G75, using a mixture of hexane:ethyl
acetate (0 to 100 %), eight fractions were separated from
the butanol fraction of the latex extract. But one of them
show the best presence of components with higher po-
larity, with solubility and affinity characteristics with the
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substrate, then this fraction was submitted to tests to ver-
ify its anticancer action, as disclosed in the “patent of the
active fraction of a polar solvent extract from the latex of
Euphorbiaceae plants” (Additional file 1) and results in de-
creased of growth of seven cancer cell lines [22].
Growth curve
Hep-2 cells were seeded in triplicate at a density of 5 × 104
cells in plastic 6-well plates and divided in three groups.
The control group was grown on complete medium, the
other groups were submitted to the addition of vehicle
(ethanol), whereas E. tirucalli latex was added to the ex-
perimental group. Twenty four (24) hours later, when the
cells had already adhered, Hep-2 cultures were incubated
with serum free medium (MEM 0 %). After an additional
24 h, the control group was maintained in complete
medium without any pharmacological manipulation,
whereas vehicle (ethanol) was added to the other groups
and E. tirucalli latex was added to the experimental group.
The cell morphology was observed on each day. The
cytotoxic effects of the E. tirucalli on the proliferation of
Hep-2 cells were investigated in three experimental
groups at 1, 3, 5 and 7 days. The cells were harvested,
stained with trypan blue and counted using the Count-
ess® Automated Cell Counter (Invitrogen®). Significant
differences between the groups were determined by one-
way analysis of variance (GraphPad Prism 5) and statis-
tical significance was assumed when P <0.05. The same
experiment was repeated twice.
RNA extraction for Rapid Subtraction Hybridization
(RaSH) and real time PCR experiments
Hep-2 cells were seeded at a density of 1 × 106 cells/ml
in 75 cm2 culture flasks in complete medium (control
group), vehicle (ethanol) was added and they were incu-
bated with E. tirucalli latex for 3 days (experimental
group). The RNA from Hep-2 cells (three groups) was
extracted using Trizol [23] following treatment with
DNase (Invitrogen). cDNA synthesis was performed
using a High Capacity cDNA Archive kit (Applied Bio-
systems, Foster City, CA, USA) according to the manu-
facturer’s instructions.
Rapid Subtraction Hybridization (RaSH)
The RaSH technique [24] was performed with two subtrac-
tions. The first was termed “Sub I”, in which the Hep-2
control cells were referred to as tester and the cells treated
with E. tirucalli latex were termed driver. In the second
subtraction, “Sub II,” the opposite test was performed.
The first cDNA strand was obtained by reverse tran-
scriptase with 2 μl of oligo (dT) (50 mM) and 2 μl of
10 mM dNTPs at 65 °C for 5 min. The samples were im-
mediately placed on ice for 1 min and 2.0 μl of 0.1 mM
DTT, 1 μl of 40 U/μl RNA-OUT and 4.0 μl of 5X First-
Strand Buffer [250 mM Tris-HCl (pH 8,3), 375 mM KCl,
15 mM MgCl2] were added. The samples were incubated
at 42 °C for 2 min and 1.0 μl of Superscript™ II reverse
transcriptase (RT) (200 U/μl) was added. The samples
were incubated again at 42 °C for 50 min and then at
70 °C for 15 min. Segments of β-actin cDNA were also
amplified to verify the quality of these reactions.
The second strand of cDNA was synthesized in reac-
tions containing 30 μl of 5X Second Strand Buffer, 3 μl
of 10 mM dNTPs, 1 μl of DNA ligase (10 U/μl), 4 μl of
DNA Pol I (10 U/μl) and 1.0 μl of RNase H (2 U/μl).
The samples were incubated for 2 h at 16 °C before the
addition of 2 μl of T4 DNA Pol (5 U/μl) and further in-
cubation for an additional 5 min. The action of the en-
zyme T4 DNA Pol was inhibited by the addition of 10 μl
of 0.5 M EDTA. Phenol/chloroform extraction was used
to purify the sample and the pellet was resuspended in
45 μl of water. The cDNA was used in amplification re-
actions for segments of GAPDH and was subsequently
digested with 2 μl of MboI enzyme (10 U/μL) and incu-
bated for 1 h at 37 °C. Finally, over 1 μl of this enzyme
was added to the reaction, and the samples were incu-
bated overnight at 37 °C.
A volume of 4.1 and 4.5 μl, of the adapters XDPN-14 5′-
CTGATCACTCGAGA and XDPN-12 5′-GATCTCTC-
GAGT (Sigma Chemical, final concentration 10 mM) was
added to the cDNA respectively, 8 μl of 5X T4 DNA ligase
buffer Invitrogen©, heated at 55 °C for 1 min, and cooled
down to 14 °C within 1 h was also added. The cDNA re-
ceived 3 μl (9 U) of T4 DNA ligase (3 U/μl), ligation was
carried out overnight at 14 °C. After phenol/chloroform
extraction and ethanol/glycogen precipitation, the mixtures
were diluted to 100 μl with TE buffer (10 mM Tris/1 mM
EDTA); 40 μl of the mixtures were used for PCR
amplification.
The PCR mixtures were set up using 10 μM XPDN-18
5′-CTGATCACTCGAGAGATC, 0.4 mM dNTPs, 10 ×
PCR buffer, 1.5 mM MgCl2 and 1U Taq DNA polymer-
ase (Invitrogen). Thermocycler conditions were one
cycle at 72 °C for 5 min, followed by 25 cycles of 94 °C
for 1 min, 55 °C for 1 min, 72 °C for 1 min, ending in a
final extension at 72 °C for 3 min. Ten (10 μg) micro-
grams of purified PCR product (tester) was digested with
10 U/μl XhoI (Invitrogen) for 6 h at 37 °C and followed
phenol/chloroform extraction and ethanol precipitation.
One-hundred nanograms of the tester cDNA were
mixed with 5 μg of the driver cDNA in hybridization
solution (0.5 M NaCl, 50 mM Tris/HCl, SDS 2 % and
40 % formamide) and, after heating at 99.9 °C for 5 min,
they were incubated at 42 °C for 1 h, and 42 °C for 48 h.
After extraction and precipitation, the hybridization
mixture (1 μg) was ligated with XhoI-digested pZero
plasmid and transformed into competent bacteria.
Bacterial colonies were picked and used as DNA
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template for PCR. Clones were sequenced using an auto-
mated DNA sequence and homologies sequences were
searched using the BLAST program. Gene ontology
(GO) annotation was used for the functional classifica-
tion of up- and down-regulated genes using terms from
Gene Ontology database.
The genes were further analyzed through Ingenuity
Pathway (IPA - Ingenuity Systems©) to relate the differ-
entially expressed genes with biological functions and
processes in which these genes are involved and evaluate
the main networks of interaction between them.
Quantitative PCR - RT-qPCR
The RNA from control, vehicle (ethanol) and E. tirucalli
latex treated Hep-2 cells was extracted and cDNA syn-
thesis was performed as described above.
Five differentially expressed genes were selected for
validation by quantitative real time PCR experiments ac-
cording to their direct or indirect involvement in
tumorigenesis. Their expression was checked in treated
samples relative to matched non-treated samples.
The primers were manually designed with: 19–23 bp
length, 30–80 % GC content and a short amplicon size
(80–120 bp). Their sequences are shown in Table 1.
Real-time PCR was performed in triplicate using a 7500
Fast Real-Time PCR System (Applied Biosystems). Reac-
tion mixture consisted of a 20 μl volume solution con-
taining 10 μl of Power SYBR Green PCR Master Mix
(Applied Biosystems).
Reaction mixture consisted of a 20 μl volume solution
containing 100 and 500 ηg of Power SYBR Green PCR
Master Mix (Applied Biosystems), 100 nM of each pri-
mer and 100 ng cDNA (control and treated with E. tiru-
calli latex). The PCR conditions were 95 °C for 10 min
followed by 40 cycles of 95° for 15 s and 60° for 1 min.
Melting curve analysis was performed for each gene to
check the specificity and identity of the RT-PCR prod-
ucts. For each primer set, the efficiency of the PCR
reaction (linear equation: y = slope + intercept) was mea-
sured in triplicate on serial dilutions of the same cDNA
sample. The PCR efficiency (E) was calculated by the
formula E = [10(-1/slope)] and ranged from 1.96 to 2.02 in
the different assays.
Two control genes (GAPDH, ACTB) were used as in-
ternal standards. The relative expression ratio (fold
change) of the target genes was calculated according to
Pfaffl [25]. Statistical analysis was performed by a two-
tailed unpaired t test using GraphPad prism software.
Results
Cellular morphology
Hep-2 cells were initially cultured and observed by
phase contrast microscopy. These cells have a fusiform
appearance and central core, with multiple nucleoli and
a eucromatic position, which are characteristics of a cell
with high metabolic activity. In cells treated with E. tiru-
calli latex [25 μg/ml], there was no morphological
change, and cytoplasmic processes were more clearly ob-
served due to reduced cell proliferation (Fig. 1a and b).
Proliferation assay
In the proliferation assay (Fig. 1c), it was possible to ob-
serve the growth inhibitory effect under treatment with
E. tirucalli latex, using the GraphPad Prism 5 (GraphPad
Software). E. tirucalli was shown to decrease the prolif-
eration in treated cells in comparison to the control
group. Statistical analysis showed that these differences
were most significant (P < 0.05) at a concentration of
25 μg/ml E. tirucalli and a culture time of 3 days.
We also observed, using the same statistical test, that
the addition of ethanol reduced cell proliferation, however,
they did not exhibit any statistically significant difference
compared to control group (Fig. 1d), confirming that the
reduced growth of Hep2 cells was due to E. tirucalli and
not its diluent’s (ethanol), (Additional files 2 and 3).
Genes identified using the RaSH approach
Rapid subtractive hybridization (RaSH) compares two
distinct experiments aiming to find differential gene ex-
pression. RaSH was performed on Hep-2 cells from the
control group and those treated with E. tirucalli latex
for 3 days and 85 clones were isolated and sequenced.
By screening these sequences through GenBank (Blast)
and by rigorous classification and selection, 19 genes
were found to be differentially expressed, and two librar-
ies of genes (Sub I and Sub II) were acquired. Fifteen
genes of the “Sub I” library exhibited changes in expres-
sion levels in the control cells, whereas four genes of the
“Sub II” library changed in expression under treatment
with E. tirucalli latex. Therefore, it was expected that
the gene expression of one library would be lower than
that of the other one. The libraries of the genes obtained
Table 1 Primers for the selected genes. ANXA1, ITPR1, CD55,
NGFRAP1 and TCEA1 primers to quantitative PCR validation
Primer Sequence
ANXA1 antisense 5′ TAAGGGTGACCGATCTGAGG 3′
ANXA1 sense 5′ ACGTCTGTCCCCTTTCTCCT 3′
ITPR1 antisense 5′ GCTCTATGAGCAGGGGTGAG 3′
ITPR1 sense 5′ GGAACACTCGGTCACTGGAT 3′
CD55 antisense 5′ CAGCACCACCACAAATTGAC 3′
CD55 sense 5′ TGCTCTCCAATCATGGTGAA 3′
NGFRAP1 antisense 5′ GGGGGAGCTCTCTAATCACC 3′
NGFRAP1 sense 5′ AAAGAAAACAGCGGGAATCA 3′
TCEA1 antisense 5′ AGCTGAAAGAGATGCGGAAA 3′
TCEA1 sense 5′ TGCCACATGTGAACAAGTCA 3′
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along with their different functions and processes are de-
scribed in the Gene Ontology (GO) databases.
IPA was used to further analyze the 19 differentially
expressed genes, which were especially associated with
tumorigenesis, apoptosis, cell proliferation, cell cycle,
DNA repair, complement activation and inflammatory
response (Table 2). Moreover, some of these genes were
chosen because they form a network of important inter-
actions with other genes such as NF-kB.
Five differentially expressed genes, ITPR1, ANXA1,
TCEA1, CD55 and NGFRAP1, were selected for valid-
ation by quantitative real-time PCR experiments.
These genes are associated with calcium ion trans-
port, inflammatory response, DNA repair, complement
Fig. 1 Morphological analysis and growth curve of E. tirucalli latex treatment in Hep-2 cell line. Hep-2 cells were seeded in complete MEM 10 %
at a concentration of 5×104 per well (6 well plate). The cell morphology observed in (a) the control group, characterized by a monolayer of nucleated
cells was not altered in (b) the E. tirucalli latex [25 μg/mL] treated group for 3 days. 400× magnification. The growth curve observed to Hep-2 cells
treated with (c) E. tirucalli latex [0.25, 2.5, 25, 250 μg/ml] for 1, 3, 5 and 7 days and (d) ethanol (vehicle) and E. tirucalli latex [25 μg/ml] for 1, 3, 5 and
7 days. Assays were performed in triplicate. Graph x = time (hours) and y = number of cells × 104. P values <0.05 were significant
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activation and apoptotic process respectively. They
were chosen because they are directly or indirectly in-
volved in tumorigenic and inflammatory processes
(Table 2 and Fig. 2).
Real-time PCR validation of differentially expressed genes
The RaSH analysis indicated the down-regulation of one
gene (ITPR1) and up-regulation of four genes (ANXA1,
TCEA1, CD55 and NGFRAP1) in Hep-2 cells treated
with E. tirucalli latex. The quantitative PCR experiment
showed that only the expression of ITPR1 was signifi-
cantly reduced, however the expression of CD55 and
ANXA1 genes was significantly increased in Hep-2 cells
after treatment with E. tirucalli latex (Fig. 3). The ex-
pression of other genes oscillated without statistical
significance, which was most likely because the E. tir-
ucalli does not quantitatively modify the expression
of the selected genes despite its interaction with the
cell (Additional file 4).
Discussion
The active fraction present in the E. tirucalli latex that
was used in our experiments inhibits proliferation of
tumor-related enzymes and presents potential anti-
inflammatory and analgesic effects [26]. Also, due to the
importance of its antitumogenic action, we analyzed the
effect of herbal medicine in the cell line of laryngeal
squamous cell carcinoma (Hep-2) and it was observed
that the morphology did not change after treatment with
E. tirucalli latex, however, cell proliferation decreased
significantly. Other authors corroborate these results,
they also observed that treatment with E. tirucalli in cell
line of breast cancer did not alter the morphology of
these cells independent on the vehicle [15]. Regarding
the reduced proliferation, E. tirucalli must have acted in
tumorigenic cells causing cell death and also causing the
growth of these cells to be reduced. In vitro, it is known
that latex works in the cell colonies fighting breast can-
cer and gastric cancer [19, 27].
The E. tirucalli latex effect was also analyzed in the
gene expression, for the first time, by RaSH that isolates
differentially expressed genes including new genes and
rare transcripts as can be seen in some researches [28]
and others who use this technology [29]. It is possible to
generate significant genomic libraries that can assist in
the search for genes differentially expressed in treated
Hep-2 cells with herbal cell lines which is faster and less
costly than other alternative hybridization techniques
[24].
The results showed changes in the expression of some
genes in the cells of LSCC after treatment with E. tiru-
calli latex, including ANXA1, TCEA1, NGFRAP1, ITPR1
and CD55 genes. These genes belong to the same gene
signaling network related by software IPA, correlating
the tumorigenic and inflammatory processes. Other au-
thors used the software IPA to identify the biological ac-
tivities of the genes that distinguish between the thermal
properties, hot (warm effects, disperse cold) or cold
(cooling effect, removes heat) of Chinese medicinal herb.
It was demonstrated that the main biological gene net-
works in the herbs with hot properties include inflam-
mation and immunity regulation while the genes of the
herbs with cold properties affect cell growth, prolifera-
tion and development [30].
The selection of the validated ITPR1 gene (inositol
1,4,5-trisphosphate receptor, type 1) can contribute sig-
nificantly to the understanding of processes including
cancer of the larynx since it has functions related to
apoptosis, tumorigenesis of cells squamous and cell pro-
liferation. Inositol 1,4,5-trisphosphate receptor type1
(IP3R1) is known as an IP3-gated Ca2+ channel that is
located on the endoplasmic reticulum (ER). The ER
stores intracellular Ca2+ and it has been reported to play
a critical role in a variety of cell functions including cell
Table 2 Genes selected by RasH in the subtractive library I expressed in Hep-2 cell line. NM is the access number in GenBank
(www.ncbi.nlm.nih.gov)
NM Name Abbreviation Chromosomal
location
Functions and processes
NM_001099952.2 Homo sapiens inositol 1,4,5-
trisphosphate receptor, type 1
ITPR1 3p26.1 Protein binding; calcium ion transmembrane transporter activity;
intrinsic apoptotic signaling pathway and signal transduction.
NM_000700.1 Homo sapiens annexin A1 ANXA1 9q21.13 Calcium ion binding; regulation of cell proliferation;
inflammatory response; cell surface receptor signaling pathway;
negative regulation of apoptotic process.
NM_006756.2 Homo sapiens transcription
elongation factor A (SII), 1
TCEA1 8q11.2 DNA repair; positive regulation of transcription from RNA
polymerase II promoter and gene expression.
NM_000574.3 Homo sapiens CD55 molecule,
decay accelerating factor for
complement
CD55 1q32 Enzyme inhibitor activity; elevation of cytosolic calcium ion
concentration and regulation of complement activation.
NM_206917.1 Homo sapiens nerve growth
factor receptor (TNFRSF1)
associated protein 1
NGFRAP1 Xq22.2 Protein binding; induction of apoptosis.
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Fig. 3 Quantitative Real time PCR gene expression in Hep-2 cells treated with E. tirucalli latex. Expression of ITPR1, ANXA1, TCEA1, CD55 and
NGFRAP1 genes in Hep-2 cells treated with 25 μg/ml of E. tirucalli latex compared with control cells. The data represent the logarithm base 2
Fig. 2 Network of gene interaction NF-KB pathway obtained from the subtraction of the control Hep-2 cells. Ingenuity Systems© software reveals a
network of gene interactions associated with cancer, squamous cell tumor, benign tumor, apoptosis, proliferation, aggregation, morphology, viability,
development and cell signaling, cell cycle control, cell membrane fusion, cleavage RNA fragment, protein transport, angiogenesis, activation of the
complement system, innate immune response, release and activation of the calcium ion, inflammatory, antimicrobial response, inherited disorders,
organ hypoplasia, oral cancer and laryngeal cancer process
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proliferation, contraction of smooth muscle and apop-
tosis by pumping out Ca2+ from ER to cytosol [31–33].
We observed reduced ITPR1 gene expression in Hep
-2 cells after treatment with E. tirucalli latex. Other pro-
ject showed that IP3 receptors act as in vivo substrates
for Akt kinase, which plays a key role in suppressing
apoptosis [34]. According to our tests, it can be inferred
that the E. tirucalli latex decreases the expression of
ITPR1 gene by restricting the action of the enzyme Akt
kinase and activating apoptosis, decreasing cell growth
of LSCC since these receptors are substrates for the ac-
tion of this enzyme.
Another gene studied was ANXA1 (Annexin 1), there
was increased expression in Hep-2 cells after treatment
with E. tirucalli latex. This gene is important for the car-
cinogenic process such as cell cycle control, regulation
of apoptosis, cell proliferation and growth, inflammatory
response and calcium ion transport regulation [35]. The
annexin family consists of ubiquitous proteins that inter-
act with phospholipids in a Ca2+-dependent manner.
Each annexin consists of an N-terminal domain and a
typical core domain. The annexin core is conserved
among all members of the annexin family. In contrast,
N-terminal domains are variable in length and are be-
lieved to regulate annexin functions, forming a truncated
molecule with altered sensitivity to calcium [36].
Changes in the expression of ANXA1 have been re-
ported in various cancers and, furthermore, its expres-
sion has been compared to that of other proteins. This
scenario prompted Jorge et al. [37] to investigate the re-
lationship between the gene and protein expression of
annexin-A1 (ANXA1/AnxA1) and galectin-1(LGALS1/
Gal-1) in an inflammatory gastric lesion as chronic gas-
tritis (CG) and gastric adenocarcinoma (GA) and its as-
sociation with H. pylori infection. High ANXA1mRNA
expression levels were observed in 90 % of CG cases and
in 80 % of GA cases. However, LGALS1 mRNA levels
were high in 60 % of the GA cases, while low expression
was found in CG. These results have provided evidence
that galectin-1 and mainly annexin-A1 are overexpressed
in both gastritis and gastric cancer, suggesting a strong
association of these proteins with chronic gastric inflam-
mation and carcinogenesis [37].
The expression of ANXA1 was evaluated in larynx
cancer and it was observed that this protein plays a
regulatory role in Hep-2 cells, decreasing the growth of
these cells [38]. We infer that the E. tirucalli latex con-
tributes to increased expression of the gene ANXA1 in
the larynx squamous cell carcinoma, confirming the role
of Annexin A1 in the regulation of cell proliferation, be-
sides the anti-inflammatory function.
The gene CD55 (decay accelerating factor) presents
functions related with squamous tumor cells, apoptosis,
cell growth and proliferation, inflammatory response,
calcium ion transport regulation and innate immune re-
sponse, according to the reported data Gene Ontology
(GO).
This gene is a key regulator affecting all three comple-
ment activation pathways and encoding a globular glyco-
protein known as DAF - decay accelerating factor. DAF
inhibits the activation of C3 and C5 by preventing the
formation of new and accelerating the decay of pre-
formed C3 and C5 convertases which can mediate the
downstream effect of all 3 complement-activation path-
ways, therefore, CD55 functions to protect host cells
from complement attack and inhibits amplification of
the complement cascade [39].
CD55 is an anti-inflammatory and immunological
anti-adhesive molecule implicated in the resolution of
ongoing inflammation of mucosal epithelia through
clearance of transmigrating neutrophils [40]. In our
tests, it was demonstrated that the expression of CD55
was elevated in cell lines of laryngeal squamous cell car-
cinoma after treatment with E. tirucalli latex, confirming
its anti-inflammatory role.
The genes evaluated in this study showed differential ex-
pression in Hep-2 cells in a manner dependent on E. tiru-
calli latex treatment. This study highlights the importance
of the RaSH technique as a fast and efficient method for
identifying genes modulated by E. tirucalli latex in cells of
epithelial origin. The functions of the genes identified in
this study are important in tumor progression and are
amenable to changes through interactions with the metab-
olism of the Hep-2 cells. The treatment for larynx carcin-
oma commonly involves surgery, chemotherapy or
radiotherapy. However, new therapeutics such as the use
of gene therapy associated with nanoparticles tested in lar-
ynx cancer derived Hep-2 cells are being developed, allow-
ing the delivery of drugs into target cells.
Furthermore, the E. tirucalli latex alters the prolifera-
tion and gene expression of Hep-2 cells. These changes
are most likely related to inflammatory and tumorigenic
processes. Thus, we suggest that the this herb has mod-
ulatory effects on the metabolism of this cell type. Our
findings suggest the importance of future studies using
Hep-2 cells for the development of new therapies. These
studies should focus on gene activities that involve the
action of E. tirucalli and applications of this herb as a
possible therapeutic in the treatment larynx carcinoma.
Conclusions
These findings show that the E. tirucalli latex alters the
expression of genes with roles in signaling cascades in-
volved in the inflammatory and tumorigenic processes.
E. tirucalli latex was also shown to alter the proliferation
of Hep-2 cells. Thus, our results point to possible appli-
cations of this herb as an indicator of innovative therap-
ies for the treatment of LSCC.
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